← All companies
RHYTHM PHARMACEUTICALS, INC.
RYTM - CIK 0001649904
Market cap$5.87 B
Rank#1281
SEC filings799
RHYTHM PHARMACEUTICALS, INC. trades as RYTM and has a market capitalization of $5.87 B, making it the #1281 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $189.76M, up 45.8% from the prior year and net income of -$196.54K. This page tracks RHYTHM PHARMACEUTICALS, INC. through 799 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$189.76MFY 2025
Net income (latest FY)-$196.54KFY 2025
Operating cash flow (latest FY)-$115.67MFY 2025
Total assets (latest FY)$480.20MFY 2025
Net margin-0.1%latest FY
Financial performance
Net profit margin expanded from -2.2% to -0.1% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $5.87 B
- Share price (derived)market cap / shares outstanding
- $85.71
- EPS (diluted)FY 2025
- $-3.11
- Shares outstandingas of 2026-05-01
- 0.07B
- Total equityas of 2026-03-31
- $122.91M
- Return on equity
- -0.2%
- Long-term debtas of 2026-03-31
- $98.34M
- Cash & equivalentsas of 2026-03-31
- $62.14M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Employee stock plan | S-8 | 2026-05-05 |
| Proxy materials | DEFA14A | 2026-05-05 |
| Quarterly report | 10-Q | 2026-05-05 |
| Major company event | 8-K | 2026-05-05 |
| SCHEDULE 13G | - | 2026-04-30 |
Recent press releases
- Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences2026-05-26
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences – Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology2026-05-12
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology – Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference2026-05-06
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference – Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update2026-05-05
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update – Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 20262026-05-05
Live webcasts of both the financial results conference call and the fireside chat will be available under "Events and Presentations" in the Investor Relations section of the Rhythm Pharmaceuticals website at http://ir.rhythmtx.com/ . The archived webcast of the financial results conference call will be available on Rhythm’s website approximately two hours after it concludes and will be available for 30 days following the call. A replay of the Needham Virtual Healthcare Conference webcast will also be available on the Rhythm website for 30 days following the presentation.
Similar companies
The largest companies sharing RHYTHM PHARMACEUTICALS, INC.'s SEC industry classification (pharmaceutical preparations).
Frequently asked questions
What is RHYTHM PHARMACEUTICALS, INC.'s market cap?
RHYTHM PHARMACEUTICALS, INC. (RYTM) has a market capitalization of $5.87 B as of 2026-06-10, ranking #1281 among US-listed companies.
How much revenue does RHYTHM PHARMACEUTICALS, INC. make?
RHYTHM PHARMACEUTICALS, INC. reported revenue of $189.76M for fiscal year 2025, an increase of 45.8% year over year.
Is RHYTHM PHARMACEUTICALS, INC. profitable?
In its latest fiscal year RHYTHM PHARMACEUTICALS, INC. reported a net loss of $196.54K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.